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     Beams of fast neutrons were produced by Kyoto University Cyclotron, using the °Be (d, n) 10B 
  reaction. 
     A number of physical properties of fast neutron fields have been measured for the purpose 
 of radiobiological experiments. These include the effectiveness of neutron collimator, the neutron 
 energy distributions, and the estimation of the neutron component and r-ray component of 
 absorbed dose in tissue. 
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                        I. INTRODUCTION 
   Intensive radiobiological researches concerning neutron radiotherapy have been 
endured since new clinical studies were undertaken with Medical Research Council 
Cyclotron at Hammersmith Hospital in London in 1968. As the results of these studies,. 
Significant advantages of neutron beams in therapeutical application are now widely 
recognized. 
   Radiobiological advantages of fast neutron beams are shown as follow ; 
1) Fast neutrons have high RBE (relative radiobiological effectiveness) values compared 
  with usually using x-rays, r-rays or electron beams. 
2) Recovery of fast neutron irradiated tumorous cells is hindered more than the cases 
  of x-rays, r-rays or electron beams. 
3) OER (oxygen enhancement ratio) values of fast neutrons are lower than those of 
  x-rays, r-rays or electron beams. 
   As mentioned above, fast neutron beams are expected to damage significantly cells 
in cancer beyond a cure with x-rays, r-rays, or electron beams. 
   Clinical trials of fast neutron beams should be performed under the following con-
ditions.1 > 
1) The 50% depth-dose for a 5 cm by 5 cm irradiation field should occur 10 cm or 
  more below the surface in a unit density tissue equivalent medium.
2) The dose rate should exceed 0. 1 Gy/min (Gy=joules/kg) on the tumor tissue. 
3) To satisfy the condition 1) and 2) neutron energy should exceed 14 MeV. 
* 1~ lij An : Nuclear Science Research Facility, Institute for Chemical Research, Kyoto 
    University, Kyoto. 
** f A3L : Department of Radiology, Faculty of Medicine, Kyoto University, Kyoto. 
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         The above conditions are currently limited by the availability of suitable neutron 
      sources. There are two reactions are generally known for fast neutron generation, One 
     such reaction is the 3H(d, n)41-le reaction, in which a beam of deuterons of fairly low 
     energy, such as 200-300 keV, are directed onto a target. In the ensuing reaction, very 
     energetic (14 MeV) neutrons are ejected with approximately uniform flux in all direc-
     tion. But the output yield with this type reaction is not sufficient for therapy at present. 
      Another useful deuteron induced reaction for producting neutron beams , occurs when 
      beam of higher energy deuterons (--14-50 MeV) impinges upon a target of low atomic 
      number, such as beryllium. In this process, the stripping process," the deuteron is torn 
      apart in passing through the target material and ejected neutrons pealk, strongly in 
      a forward direction." The mean energy of neutrons, En in MeV, produced by born-
     berding thick beryllium target with deuterons of various energies is derived as a function 
      of incident deuteron energy Ed in MeV from the experimental results." 
En=0. 43Ed(,1) 
      And the dose rate D in wet tissue is exressed as follows," 
D =2. 7 X 10-6Ed2.7 Gy/ (pA• min)(2 ) 
     at a distance of 1.25 m from the source (1.25 m SSD). 
         At Kyoto University Cyclotron, the average absorbed dose rate should be ; about 
      8 x 10-8 Gy/min at 1. 25 m SSD from this formula. 
         However this value is not sufficient for therapy that requires the dose rate more 
     than 0. 1 Gy/min, if the SSD 0. 5 m is chosen, the absorbed dose 0. 05 Gy/min should 
     be achieved and the value should be enough for basic research for the studies of the 
      biological effect of fast neutron. In this paper, we will describe the design parameters 
     to be met in developing facilities for preliminary experiments of clinical trials. 
                               II. FACILITIES 
     1. Layout of the Cyclotron 
        The 1. 05 m Kyoto University Cyclotron is a fixed energy ordinary cyclotron produc-
      ing 7. 5 MeV protons, 15-MeV deuterons and 30-MeV as.s' 
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            Fig. 1. Layout of the cyclotron and fast neutron treatment area. 
A : Magnet, B : Dee stem, C : Dee, D : Dummy dee, E : Ion source, 
F : Deflecter, G : Target assembly, H : Neutron monitor, I : Collimator, 
J: Absorbed dose measurement position (SSD =0.48m). 
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    Figure 1 shows a layout of the cyclotron and fast neutron treatment area. A target 
 assembly is connected with the beam exit of the cyclotron. The deuteron beam current 
 at  the  radius of final acceleration is 25 pA or less, however, at the exit of the cyclotron 
it is reduced to 3 pA or less. 
2. Target Assembly 
    Neutrons are produced by deuteron bombarment on water-cooled beryllium target, 
 2. 0 mm thickness. The target assembly is shown in Fig. 2. The target size is a 2. 5 cm 
by 5.'0-cm. ' Deuterons, and the other secondary charged particles are stopped in the 
 beryllium target, in cooling water or in the aluminium backing plate. 
 3. Neutron Beam Monitoring 
    The target assembly was electrically isolated from the beam tube and connected to 
 a currentmeter. An ionization chamber was placed behind the target assembly for neu-
 tron intensity monitoring. The chamber was a flat cylidrical type and had three 2.0 
 mm parallel Lucite plates, which were coated with graphite; and two 7. 0 mm air gaps. 
 Between the central and side plates in the chamber, 500 V was supplied. The chamber 
 was calibrated nominal to indicate tissue absorbed dose on the beam direction at 0.48 
 m SSD. 
4 Collimation System 
We made a beam spot of fast neutrons conform to the tumor size using a collima-
 tion system in Fig. 3. Materials constructing the collimation system should be chosen so 
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                                                                                    and neutron monitoring ionization chamber. Fig. 3. Cross section of collimator.
        The 14-MeV deuteon beam is incident onBeam spot size : 4cm by 6cm, 
        the thick Be target. A monitoring chamberCollimator length : 40cm (30cm 
was located 2. 8cm from the target.of iron, 10cm of paraffin-boron 
                                                             mixture). 
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     as to shield fast neutron effectively. The collimator had an overall length of  40 cm; 
     30 cm of iron and 10 cm of paraffin-boron mixture. Iron has a large value of macro-
     scopic effective neutron removal cross section,7> hydrogen, which is contained fair amount 
     in paraffin, scatters fast neutrons and reduces their kinetic energy effectively, and boron 
     absorbs thermal neutrons. The collimator defined a 4 cm by 6 cm radiation field at 
     the exit. Most measurements using ionization chamber were made in air at 0.48 m 
     SSD. To reduce the neutron and r-ray background from the adjoining area, the 
     irradiated field was surrounded by blocks of paraffin and lead. 
III. MEASUREMENTS 
    1. Measurements of Collimation
        To measure the effectiveness of the collimator, a foil activation method was taken. 
    We employed a 2TAl(n, p) "Mg reaction because of having a suitable threshold energy 
    2. 1 MeV, and also aluminium is easy to deal with.. 
        At the exit of the collimator, segments of aluminium plates, 0. 5 cm x 1. 0 cm x 
0. 2 cm, were arranged in a row. 
        After the irradiation by neutrons, the relative intensities of neutrons were derived 
     from the activation measurements. The results are shown in Fig. 4. A neutron intensity 
    at a shadow 3.5 cm from the edge of the aparture was reduced to 13% from the 
    maximum value. These data show that the fast neutrons exceeding 2. 1 MeV were 
    well collimated by the system. 
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                 Fig. 4. Relative intensities of fast neutrons at the exit of the collimator 
                       by activation method : 27A1(n, p)27Mg 
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      2. Measurements of the Energy Spectra 
          Neutron energy at 0° were measured using the time-of-flight (TOF) techniques. 
       The experimental setup is shown in Fig. 5. The technique requires short neutron bursts 
       and a detector with fast time response. The neutron bursts were produced by the 
       cyclotron self-bunching beam. The repetition rate was the same as the frequency of the 
      cyclotron rf, 13. 05 MHz. A NE 213 organic liquid scintillator, 5. 1 cm in diameter by 
5.1 cm in length, coupled to a Philips 56DVP photomultiplier tube was used to detect 
       the neutrons at a distance of 1. 355 m from the target. 
          A 23 cm long iron collimator having a 2. 4 cm by 2. 0 cm aperture was placed in 
       front of the detector, which was housed in the iron and lead shield to reduce room 
       associated background. 
          The time interval between the bursts was 77 n sec, which was the TOF of 1. 6-
       MeV neutron travelling 1. 36 m. 
          The starting signal was taken from the anode of PM tube. The signal was shaped 
by a constant-fraction discriminator (ORTEC 271) and a 'time-pickoff-control (ORTEC 
403A) , and was supplied to a time-to-amplitude converter (TAC: ORTEC 437A) . The 
      stopping signal taken from the cyclotron rf was supplied to the TAC, too; after shaped 
      and delayed. The output signal of the TAC was connected to the input of an analog-
      to-digital converter (ADC: NS-623). All data-taking was done with an on-line compu-
      ter (HP 2100). 
          Dead time of the ADC were kept to less than 13% in all measurements. 
          Mononergetic neutrons, En=3.2 MeV, 4.3 MeV and 5.3 MeV produced by a 
            n) 7Be reaction, were used to determine the relative efficiencyof the neutron 
        detector. 
          The evaluation of the r-rays contribution and the background neutrons were made 
      by placing lead or beryllium absorber. The neutron energy spectrum shown in Fig. 6 was 
      obtained from the TOF data correcting the detector efficiency and the background 
       evaluations mentioned above. 
          The present data are in substantial agreement with the other measurements"") 
      and the value derived from the Eq. (1) . 
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         Fig. 5. Schematic illustration of the TOF 
        experimental setup. o 2 4 6-----------------------------------------------------e (o iz w 16 
             Flight path : 1. 36m,NEUTRON ENERGY ( MeV) 
A : Trget assembly,Fig. 6. Neutron spectral distribution from 
               B : Iron shield (23cm in length, 2.0Be+d reaction in thick target.
                  cm by 2. 4cm collimation).Target thickness : 2. 0mm. 
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3. Dose Measurements 
             One of the most general methods for determining absorbed dose should be ionization 
          measurements in gases. Absorbed dose can be estimated using the relation between the 
          ionization produced in a gas—filled cavity at the place of interest in the material irradiated 
          and the energy imparted to unit mass of the material. This is known as the Bragg-Gray 
          relation.") The dose D in Gy can be written as, 
D=Q•(W/e)•S/M,•(3) 
           where 
             Q =the ionization in coulombs, 
             W=the average energy in joules expended by the ionizing particles crossing the 
                  cavity, 
             e =the charge of the electron in coulombs, 
             S =the effective mass stopping power ratio of medium to that of the cavity gas for 
                 those ionizing particles, 
             M=the mass of the gas in kg. 
             When dose measurements were made by the ionization chamber method, the operating 
         conditions of a chamber should be arranged to give less than 1% loss of charge by 
          recombination, if possible. 
             Recombination is usually classified as the term of general or initial recombination. 
            General recombination increases with radiation intensity, which is the dose rate usually 
         in dosimetry. Whereas, initial recombination is independent of the dose rate. The amount 
         of initial recombination depens upon the LET of the ionizing particle and the strength 
         of collecting field. 
            As long as the chamber is used to measure the dose of low LET radiation such as 
          x-ray or r-ray, initial recombination will not affect the measurements. ' = Therefore, the 
          criterion that the loss of ions by general recombination can be neglected should be 
          determined by r-ray calibration of known dose rate. 
             The measurements of absorbed dose were performed with two cylindrical ionization 
          chambers shown in Fig. 7. The upper limit to the dose rate of the each chamber was 
         checked by irradiation in the Cs-137 standard field of values from 1.8R/min to 29. 9R/ 
min of exposure dose. The each upper limit was 17R/min when the chambers were 
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                                  Fig. 7 Cross section of ionization chamber, 
                                           TEP-TEG and C-air chambers. 
(152)
                      Fast Neutron Fields Produced by Kyoto University Cyclotron 
      supplied more than 200 V. As the maximum observed dose rate 0. 1 Gy/min at 0. 48 m 
      SSD obtained with the cyclotron was nearly half of 17 R/min, which corresponds to 
      0.  18  Gy/min, the correction of general recombination effect should be neglected. 
Significant initial recombination may occur when the ionization by high LET particles 
      is measured with the chamber. As the case, good plateau cannot be observed in 
      saturation measurements, field strength vs. current curve measurements. 
         Generally, initial recombination is shown in the following relation,") 
1/i=1/isat+constant/x,(4 ) 
      where, i is observed ionization current, ism is true saturation current, x is an appropriate 
      function of the collecting field strength. If the reciprocal of the measured current, 1/i, is 
plotted against 1/x a straight line will be obtained and a correction factor will be esti-
      mated. To determine the value of isat, the chamber current was measured varying the 
      supplied voltage from 0 V to 1000 V under the dose rate which could neglect the 
general, recombination. The difference between the actually isat and i was less than 
      0. 1%. This value lies within the overall uncertainty of measurements with the ionization 
       chamber. 
One of the ionization chambers was constructed of tissue equivalent (TE) plastic 
(C:. 78.;9 wt%, H: 10. 1 wt%, 0: 4. 8 wt%, N: 3. 5 wt%, Ca: 1. 8 wt%, and F: 1. 7 
wt%) 13; and was filled with TE gas (64. 4% CH4, 32. 4% CO2, and 3. 2% N2). It 
had 'a:nominal cavity volume of 1.3 cm' with a wall thickness of 2.0 mm. Another 
      chamber had a dimension approximately equal to that of the TE chamber, but was 
      constructed of carbon and filled with air. A cross section of the ionization chambers is 
shown, in, Fig. 7. 
         The TE chamber was used to determine the total absorbed dose in tissue, and 
the carbon-air (C-air) chamber was used to evaluate the relative component of r-rays 
      to total absorbed dose. 
The response of these chambers, Q; (in coulombs), in a mixed n-I field is given 
by i 4; 
Qi=A;Dr+B;Dn>(5 ) 
where Dr and, Du are the r and n tissure dose in Gy respectively, and Ai (i means 
      TE chamber or .0-air chamber) and B; are the absorbed dose conversion coefficients 
      in coulombs/Gy for r-rays and neutrons, respectively. 
         The values of the r-ray sensitivity A, were readily determined to be 4. 70 x 10-8 
      coulombs/Gy ± 2. 4% for the TE chamber and 5. 27 x 10-8coulombs/Gy ± 2. 4% for the 
      C-air chamber, by measuring the Cs-137 r-ray fields. 
         The Eq. (5) is divided by Ai for calculational convenience and written as 
(Qi/Ai) =Dr+ (B/A);Dn (6 ) 
     where B;/Ai is defined as (B/A) i. 
         The values of B;, the neutron sensitivity for TE chamber or C-air chamber, were 
      calculated from (B/A) i using the Bragg-Gray relation, respectively. That is, 
(B/ A) TE= (W TEO> r X S TEa>r) / (W TEG, nX .STEQ, n) >(7 ) 
(153)
                       J.  MIYAJIMA, T. NISHIDAI, and H. TAKEKOSHI 
(B/A)C-air=(wair,rXSair,rXKT)/(wair,nXSair,nXFT),  (8) 
    where, 
   w =W/e, W and e are same one appeared in the Eq. (3), 
   S =the effective mass stopping power ratio of the chamber wall material (TEP or 
       carbon) to the gas (TEG or air) for r-rays or neutrons, respectively, 
   K =the ratio of kerma of carbon to that of tissue for fast neutrons, 
   F =the ratio of the mass energy-absorption coefficient of carbon to that of tissue 
       for the Cs-137 r-radiation. 
Values of wTEa,r=29. 2 joules/coulomb,15) wTEG,n=30. 5 joules/ coulomb,") STEa' r, 115) 
and STEQ,n 115) were used in a homogeneous chamber in the calculation for the 
Eq. (7) . As the result, the ratio (B/A) TE was determined to be 0. 96. In the Eq 
(8), values of wair,r=33.7 jouls/coulomb,15j  = 34. 9 joules/ coulomb,") Saii,r= 
1.01,14j S'ir,,,Sair,p=1.0416) and FT=0.90614) were used. The ratio of kerma KT= 
0. 116 was obtained by weighted-averaging over the measured neutron energy spectrum 
in Fig. 6 using the kerma value for each neutron energy calculated by Caswell et al.is, is) 
   The value of (B/A)c_air was calculated to be 0. 12. 
   It becomes possible to separate the absorbed dose due to neutrons and that of r-
rays by using the values of Ai, Bi. 
   In the measurements of the absorbed dose in air, the chamber wall should be thick 
enough that most of the secondary particles produced in air can not reach the cavity 
of the chamber. But the chamber wall absorbs and scatters the primary radiation; so 
it is undesirable to make the wall any thicker than is necessary. It implies the satisfac-
tion for the charged particle equilibrium (CPE) conditioni4,2o) in the cavity and its 
immediate surroundings. 
   From the consideration of the CPE criterion, it should be optimum for a wall thick-
ness to be equal to the maximum range of the most energetic secondary particles. The 
most energetic protons generated in TE plastic by 9 MeV neutrons have a range of 
1. 1 mm.21) The neutrons higher than 9 MeV was less than 30% in measured neutron 
energy spectrum. The secondary particles generated in carbon by neutrons are mainly 
a-particles and even the most energetic secondary has a shorter range than the secon-
dary protons produced by 9 MeV neutrons. So, the actual wall thickness should be 
enough to be CPE with netrons. However, a wall thickness 2. 0 mm is somewhat thinner 
than the maximum range of the secondary electrons of the Cs-137 r-rays, that is - 4. 5 
mm.14) Put a 2. 5 mm thick cap on the chamber, the resultant wall thickness is 4. 5 mm and 
the CPE condition for the Cs-137 r-rays will be satisfied. Whether the difference between 
the two cases would be able to observe or not was examined by current measurements 
in the Cs-137 r-field. The difference being due to thickness were estimated less than 
2. 4% for measured currents in both TE and C-air chambers. 
   Thus, the absorbed doses due to neutrons and r-rays were obtained in the n-r 
mixed field produced by the cyclotron. The raito of the r-ray component to the neu-
tron component, Dr/Dn, is 0.3±0.02 in tissue absorbed dose measurements at 0. 48 m 
SSD. The averaged dose rate was about 0. 06 Gy/min at that point. 
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    4. Biological Characteristics of the Neutron Beam 
        As the preliminaly clinical trials, the RBE values of fast neutron beams produced 
     by the cyclotron were measured by a  group  of Professor Abe of Kyoto University Hospital. 
    The outline of the' results is presented in the following.") 
        Relative effectiveness of fast neutron beams vs Co-60 r-rays, Cs-137 r-rays and 32 
     MeV electron beams were derived from the each dose response . curve on the growth 
     delay-time for, C3H/He mouse mammary carcinoma. 
        The values were reduced continuously from 5.0 to 3. 0 as compared with Cs-137 r 
    rays (0.-15 Gy/min) and from 4.2 to 2.7 as compared with 32-MeV electron beams 
     (15 Gy/min) . However, the values as compared with Co-60 r rays (1. 5 Gy/min) were 
    smaller than those compared with 32-MeV electron beams on 1 to 6 growth delay-days, 
    and were similar to those for Cs-137 r rays on 8 to 20 growth delay-days. 
       The results are shown in Figs. 8 and 9. 
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     Fig. 8. Dose response curves on growth delay- Fig. 9. Relative effectiveness of n-r mixed beams or 
            time for C3H/He mouse mammaryfast neutrons alone (0.05-0.06Gy/min),
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                          ACKNOWLEDGMENTS 
       The authors wish to thank Dr. T. Hiraoka of National Institute of Radiological 
Sciences, Chiba, for his advice on design of the TE chamber and for supplying them 
    with TE plastics. They are also indebted to professors M. Abe and T. Yanabu for 
    drowing for their attention to this problem and wish to thank to staffs of the Kyoto 
    University Cyclotron for their helps. This paper is dedicated to professor S. Shimizu on 
     the commemoration of his retirement. 
(155)
                         J.  MIYAJIMA, T. NISHIDAI, and H. TAKEKOSHI 
                          REFERENCES 
(1) P. Wooton, K. Alvar, H. Bichsel, J. Eenmaa, J. S. R. Nelson, R. G. Parker, K. A. Weaver, 
           D. L. Willams, and W. G. Wyckoff J. Canadian Associat. Radial., 26, 44 (1975). 
(2) R. Serber, Phys. Rev., 73, 1008 (1947). 
(3) L. S. August, F. H. Attix, G H. Herling, P. Shapiro, and R. B. Theus, Phys. Med. Biol., 
          21, 931 (1976). 
(4) C. J. Parnell, G. D. Almond, and J. B. Smathers, Phys. Med. Biol., 17, 429 (1972). 
(5) K. Kawashima, Jap. J. Cancer Clinics, 23, 268 (1977). 
(6) Y. Uemura, K. Fukunaga, S. Kakigi, T. Yanabu, N. Fujiwara, T. Ohsawa, H. Fujita, T. 
           Miyanaga, and D. C. Nguyen, Bull. Inst. Chem. Res., Kyoto Univ., 51, 87 (1974). 
(7) S. G. Tsypin, Atomnaya Energiya, 12, 300 (1962). 
(8) M. A. Lone, Symposium on Neutron Cross Sections from 10 to 40 Mev held at BNL, May 
          3-5, 1977, BNL-NCS-50681, 79 (1977). 
(9) M. A. Lone, C. B. Bighorn, J. S. Fraser, H. R. Schneider, T. K. Alexander, A J.Ferguson, 
           and A. B. McDonald, Nucl. Instr, & Meth., 143, 331 (1977). 
       (10) M. J. Saltmarsh, C. A. Ludemann, C. B. Fulmer, and R. C. Styles, Nucl. Instr. & Meth., 
          145, 81 (1977). 
      (11) T. E. Burlin, Radiation Dosimetry, vol. I, (Academic Press) 332-392 (1966). 
       (12) P. B. Scott and J. R. Greening, Phys. Med. Biol., 8, 51 (1963). 
       (13) T. Hiraoka, K. Kawashima, K. Hoshino, and H. Matsuzawa, Nippon Ac.ta., Radial., 25, 420 
         (1976). 
      (14) ICRU Report 10b, NBS Handbook 85, (1962). 
      (15) A. R. Smith, Med. Phys., 2, 195 (1975). 
      (16) H. Bichsel, Univ. of Washington InternaI Report 077.5 (1977). 
      (17) R. L. Caswell and J. J. Coyne, Radiat. Res., 52, 448 (1972). 
       (18) R. L. Bach and R. S. Caswell, Radiat. Res.,35, 1 (1968). 
       (19) J. W. Boag, Radiation Dosimetry, vol. II, (Academic Press) (1966). 
      (20) C. F. Williamson, J. P. Boujet, and J. Picard, Report CEA-R3042 (Saclay)• 
       (21) T. Nisidai, M. Abe, Y. Yukawa, S. Suyama, J. Miyajima,and H. Takekoshi, J. Jap. Soc. 
Cancer Ther., 14, 1 (1979). 
• (156)
